by Randi Fredricks, Ph.D. | Jun 19, 2023 | Addiction, Anxiety, Complementary and Alternative Medicine, Depression, Psychotherapy |
In October 2019, the U.S. Food and Drug Administration (FDA) approved esketamine, a substance chemicallyrelated to the party drug ketamine, as a nasal spray to treat depression (Bahr, 2019). The effectiveness of ketamine for depression was first shown in studies in...
